Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Non Operating Income (2022 - 2025)

Historic Non Operating Income for Lexaria Bioscience (LEXX) over the last 7 years, with Q4 2025 value amounting to -$22081.0.

  • Lexaria Bioscience's Non Operating Income fell 3869.1% to -$22081.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$36857.0, marking a year-over-year decrease of 4426.0%. This contributed to the annual value of -$30697.0 for FY2025, which is 4471.4% up from last year.
  • According to the latest figures from Q4 2025, Lexaria Bioscience's Non Operating Income is -$22081.0, which was down 3869.1% from -$8631.0 recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Non Operating Income registered a high of $34040.0 during Q1 2025, and its lowest value of -$134902.0 during Q3 2023.
  • For the 4-year period, Lexaria Bioscience's Non Operating Income averaged around -$22061.9, with its median value being -$15921.0 (2024).
  • In the last 5 years, Lexaria Bioscience's Non Operating Income plummeted by 33927.97% in 2024 and then soared by 12289.16% in 2025.
  • Over the past 4 years, Lexaria Bioscience's Non Operating Income (Quarter) stood at -$73887.0 in 2022, then skyrocketed by 37.88% to -$45896.0 in 2023, then surged by 65.31% to -$15921.0 in 2024, then plummeted by 38.69% to -$22081.0 in 2025.
  • Its Non Operating Income stands at -$22081.0 for Q4 2025, versus -$8631.0 for Q3 2025 and -$40185.0 for Q2 2025.